SenesTech, Inc.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: US81720R5054
USD
2.92
0.21 (7.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

21.71 k

Shareholding (Mar 2025)

FII

0.56%

Held by 2 FIIs

DII

98.59%

Held by 1 DIIs

Promoter

0.00%

How big is SenesTech, Inc.?

22-Jun-2025

As of Jun 18, SenesTech, Inc. has a market capitalization of 6.70 million and reported net sales of 1.92 million with a net profit of -6.01 million over the last four quarters.

Market Cap: As of Jun 18, SenesTech, Inc. has a market capitalization of 6.70 million, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, SenesTech, Inc. reported net sales of 1.92 million and a net profit of -6.01 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 2.51 million and total assets of 3.28 million.

Read More

What does SenesTech, Inc. do?

22-Jun-2025

SenesTech, Inc. is a biotechnology company focused on managing animal pest populations through fertility control, operating in the micro-cap Chemicals & Petrochemicals industry. As of March 2025, it reported net sales of $0 million and a net loss of $2 million, with a market cap of $6.70 million.

Overview: <BR>SenesTech, Inc. is a biotechnology company that specializes in managing animal pest populations, particularly through fertility control, and operates within the Chemicals & Petrochemicals industry in the micro-cap market.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 6.70 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.49 <BR>Return on Equity: -208.06% <BR>Price to Book: 2.32<BR><BR>Contact Details: <BR>Address: 3140 N Caden Ct Ste 1, FLAGSTAFF AZ : 86004-9428 <BR>Tel: 1 928 7794143 <BR>Website: https://senestech.com/

Read More

Should I buy, sell or hold SenesTech, Inc.?

22-Jun-2025

Who are in the management team of SenesTech, Inc.?

22-Jun-2025

As of March 2022, the management team of SenesTech, Inc. includes Dr. Jamie Morrison (Independent Chairman), Mr. Kenneth Siegel (CEO), and several independent directors: Ms. Delphine Chiavarini, Mr. Marc Dumont, Mr. Phil Grandinetti, Ms. K. Kavanagh, and Mr. Jake Leach. The team features a blend of executive leadership and independent oversight.

As of March 2022, the management team of SenesTech, Inc. includes the following individuals:<BR><BR>- Dr. Jamie Morrison, Independent Chairman of the Board<BR>- Mr. Kenneth Siegel, Chief Executive Officer and Director<BR>- Ms. Delphine Chiavarini, Independent Director<BR>- Mr. Marc Dumont, Independent Director<BR>- Mr. Phil Grandinetti, Independent Director<BR>- Ms. K. Kavanagh, Independent Director<BR>- Mr. Jake Leach, Independent Director<BR><BR>This team comprises a mix of executive leadership and independent directors.

Read More

Is SenesTech, Inc. overvalued or undervalued?

20-Sep-2025

As of March 16, 2023, SenesTech, Inc. is classified as risky due to its negative P/E ratio and poor returns on capital and equity, indicating it is overvalued compared to peers, despite a recent 41.69% year-to-date return, which is overshadowed by a long-term decline of 99.55% over three years.

As of 16 March 2023, the valuation grade for SenesTech, Inc. moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued, given its negative P/E ratio and concerning returns on capital and equity, which stand at -408.69% and -208.06%, respectively. Additionally, the price-to-book value is 1.74, while the EV to EBITDA and EV to EBIT are both negative at -0.61 and -0.60, respectively.<BR><BR>In comparison to its peers, SenesTech's valuation metrics are significantly weaker; for instance, Oil-Dri Corp. of America has a P/E ratio of 25.16, highlighting the disparity in financial performance. Other peers like LSB Industries, Inc. and Piedmont Lithium, Inc. also exhibit negative P/E ratios of -18.11 and -3.56, respectively, reinforcing the risky classification for SenesTech. Despite a strong year-to-date return of 41.69% compared to the S&P 500's 12.22%, the long-term performance shows a decline of 99.55% over three years, suggesting that the recent uptick may not be sustainable.

Read More

Is SenesTech, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, SenesTech, Inc. shows a bullish trend with a year-to-date return of 41.69%, despite mixed technical indicators suggesting some caution.

As of 12 September 2025, the technical trend for SenesTech, Inc. has changed from mildly bullish to bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The Bollinger Bands show a mildly bullish stance on both weekly and monthly time frames. Daily moving averages are also mildly bullish, suggesting short-term strength. However, the weekly KST and OBV are mildly bearish, which could indicate some underlying weakness.<BR><BR>In terms of performance, the company has a year-to-date return of 41.69%, significantly outperforming the S&P 500's 12.22% during the same period. Over the past year, SenesTech has returned 71.17%, compared to the S&P 500's 17.14%. Overall, the current technical stance is bullish, but with some caution due to mixed indicators.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Poor long term growth as Operating profit has grown by an annual rate 6.44% of over the last 5 years

 
3

Positive results in Jun 25

4

Risky - Negative EBITDA

5

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 25 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.83

stock-summary
Return on Equity

-86.70%

stock-summary
Price to Book

3.56

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-40.41%
0%
-40.41%
6 Months
3.55%
0%
3.55%
1 Year
29.78%
0%
29.78%
2 Years
-69.62%
0%
-69.62%
3 Years
-3.95%
0%
-3.95%
4 Years
-99.88%
0%
-99.88%
5 Years
87.18%
0%
87.18%

SenesTech, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
23.56%
EBIT Growth (5y)
6.44%
EBIT to Interest (avg)
-7.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.39
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.42%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.74
EV to EBIT
-0.60
EV to EBITDA
-0.61
EV to Capital Employed
2.44
EV to Sales
1.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-408.69%
ROE (Latest)
-208.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.86%)

Foreign Institutions

Held by 2 Foreign Institutions (0.56%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 20.00% vs 0.00% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 5.88% vs -30.77% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.50",
          "chgp": "20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-1.60",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.60",
          "val2": "-1.70",
          "chgp": "5.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,582.40%",
          "val2": "-3,428.90%",
          "chgp": "84.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 58.33% vs 20.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.48% vs 20.62% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.90",
          "val2": "1.20",
          "chgp": "58.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.10",
          "val2": "-7.60",
          "chgp": "19.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.20",
          "val2": "-7.70",
          "chgp": "19.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,365.10%",
          "val2": "-6,481.10%",
          "chgp": "311.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.60
0.50
20.00%
Operating Profit (PBDIT) excl Other Income
-1.60
-1.60
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.60
-1.70
5.88%
Operating Profit Margin (Excl OI)
-2,582.40%
-3,428.90%
84.65%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 20.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 5.88% vs -30.77% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1.90
1.20
58.33%
Operating Profit (PBDIT) excl Other Income
-6.10
-7.60
19.74%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.20
-7.70
19.48%
Operating Profit Margin (Excl OI)
-3,365.10%
-6,481.10%
311.60%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 58.33% vs 20.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 19.48% vs 20.62% in Dec 2023

stock-summaryCompany CV
About SenesTech, Inc. stock-summary
stock-summary
SenesTech, Inc.
Chemicals & Petrochemicals
SenesTech, Inc. is a biotechnology company that has developed a technology for managing animal pest populations, initially rat populations, through fertility control. Its product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. Its pipeline includes feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Its Feral animal fertility control has its application in the population management segment and targets feral dogs and hogs. Its Non-Surgical Spay and Neutering have its application in companion animal health, and targets companion dogs and cats. The Company's Boar taint has its application in food production and safety and targets boars.
Company Coordinates stock-summary
Company Details
3140 N Caden Ct Ste 1 , FLAGSTAFF AZ : 86004-9428
stock-summary
Tel: 1 928 7794143
stock-summary
Registrar Details